Sign Up to like & get
recommendations!
1
Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2017.10.027
Abstract: ABSTRACT Chronic cerebral hypofusion (CCH) promotes hyperphosphorylation of tau proteins, a key neuropathological trait that reflects neurodegenerative disorders. Nimodipine, an L‐type calcium channel antagonist, has been reported to show neuroprotective effects. In this study, we…
read more here.
Keywords:
tau phosphorylation;
gsk bgr;
phosphorylation ser396;
mir 132 ... See more keywords